William M. Hillner, PhD, is an oncologist and cancer researcher based in Chattanooga who combines clinical practice with research leadership, serving both as a treating physician and as the Medical Director of Oncology Services at a major regional cancer center. His practice bridges evidence-based treatment and investigational protocols, making him relevant for patients navigating standard care versus clinical trial options in East Tennessee.
Hillner holds a PhD in oncology and operates as both a practicing medical oncologist and research administrator. Unlike primary-care physicians or general internists, medical oncologists specialize exclusively in cancer diagnosis, treatment planning, and long-term management. Hillner's dual role means he has oversight authority over oncology service lines at his institution while maintaining individual patient caseloads, a structure that positions him to influence treatment protocols and clinical trial access across his practice network. His research background distinguishes him from community-based oncologists who focus primarily on delivering established treatment regimens without active research involvement.
Hillner's practice covers medical oncology, the branch that uses chemotherapy, targeted therapies, immunotherapy, and hormone therapy to treat cancer systemically. Medical oncology differs from surgical oncology (which removes tumors) and radiation oncology (which uses targeted radiation); patients typically see a medical oncologist after a surgeon has biopsied or removed a tumor, or as the primary treatment provider for cancers best managed without surgery. Hillner's role as Medical Director suggests he guides decisions about which therapies are available at his center and may determine which clinical trials enroll new patients in Chattanooga rather than requiring travel to larger academic centers.
Chattanooga has multiple cancer care pathways. Community-based medical oncologists in private practice or hospital-affiliated clinics typically offer established chemotherapy and targeted therapies, with strong turnaround and continuity for patients already diagnosed. Academic research centers and university-affiliated medical centers like Vanderbilt's cancer program (based in Nashville but accepting Chattanooga patients) emphasize clinical trials and access to newer drug combinations; Hillner's position as a research-engaged oncologist at a Chattanooga institution means trial access may be available locally rather than requiring commute to Nashville. Patients seeking convenience and familiar continuity choose local private oncologists; those prioritizing access to investigational therapies or complex rare-cancer expertise may benefit from Hillner's research network.
New oncology patients typically arrive via physician referral after a cancer diagnosis is confirmed by biopsy or imaging. Scheduling usually requires a referral; walk-in oncology appointments are not standard practice because treatment planning depends on prior pathology reports, imaging, and sometimes genetic testing. Lead times for initial consultation generally range from one to three weeks depending on urgency and volume, though oncology clinics often expedite urgent cases (new diagnoses of aggressive cancers) to within days. Insurance verification happens during scheduling; most major insurers are accepted, but specific coverage for investigational therapies or clinical trials should be confirmed before the first appointment.
Bring all prior pathology reports, imaging results (preferably as digital files or imaging CDs), prior treatment records if you have had cancer before, a list of current medications, and any family history of cancer. Expect the first appointment to last one to two hours. The oncologist reviews your case, performs a physical exam, may order additional imaging or blood work, and discusses treatment options. Patients with access to Hillner's research portfolio leave with clarity on whether clinical trial enrollment is appropriate for their cancer stage and type.
Specific current hours and parking details for Hillner's clinic require direct contact with his practice or the host institution's scheduling line, as oncology clinic hours often adjust seasonally and parking can vary by building affiliation. Verify appointment availability and location when calling for a referral; Chattanooga's main cancer centers are distributed across multiple locations downtown and in suburban centers, and oncology appointments are not offered at all hospital branches.
Hillner's practice suits patients with newly diagnosed or relapsed cancer who want treatment from an oncologist with research leadership and potential access to clinical trials without traveling to Nashville. It also suits patients interested in understanding emerging therapies or participating in studies. The practice does not suit patients seeking primary prevention counseling (a role for primary-care doctors or genetic counselors) or those needing routine chemotherapy infusions only, who may receive faster scheduling through smaller dedicated infusion centers. Patients whose insurance does not cover care at his institution or who require frequent appointments and live far from Chattanooga may prefer closer alternatives.
Hillner's combination of clinical practice and research direction makes him a valuable resource in Chattanooga's oncology landscape, particularly for patients seeking coordinated care with exposure to clinical trial options that would otherwise require Nashville travel.
